Pharmacovigilance Market Size, Share, Sales, Analysis, Forecast By Type (EHR Mining, Spontaneous Reporting, Cohort Event Monitoring, Targeted Spontaneous Reporting, and Intensified ADR Reporting), By Product Life Cycle (Pre-clinical, Phase I, Phase II, Phase III, and Phase IV), By Service Provider (In-house and Outsourcing), By Process Flow (Risk Management System, Signal Detection, and Case Data Management), By Therapeutic Area (Respiratory Systems, Oncology, Cardiology, Neurology, and Others), By End Use (Medical Device Manufacturers, Biotechnology Companies, Pharmaceuticals, and Other), By Geography, Industry Competition & Player Profiles, 2023 - 2032

Report code : IS543, Status : Published, Published on: Nov, 2020, Pages : 155 Pages, Format : PDF/PPT/Excel

Buying Options

Global Analysis: : $999

Global and Regional Analysis : $2799

Global Deep Dive Analysis : $5499

Competition Analysis : $399

Buy Now

Enquiry before buying

Description

The anticipated value of the global pharmacovigilance market in 2021 was $4.9 billion, and it is projected to increase at a CAGR of 14.5% through 2032.

Rising occurrences of chronic diseases such as respiratory disorder, oncological diseases, cardiovascular, and diabetes has resulted in a rapid upsurge in drug consumption across the globe. This in turn, led to rising demand for new drug development via widespread clinical trials. Pharmacovigilance plays an integral role in process of drug development and discovery. Also, rising occurrences of Adverse Drug Reactions (ADRs) is anticipated to increase the demand for pharmacovigilance services.

Furthermore, the appearance of COVID-19 pandemic hampered the market growth at the maximum extent. Threat of coronavirus infection has affected lives, communities, and businesses worldwide. Several potential therapies are being used to treat coronavirus induces infection therefore medical monitoring and reporting are necessary. Medications like Remdesivir and some other existing drugs including hydroxychloroquine, and Ritonavir/Lopinavir are being used to treat the infected patients.

A database named VigiBase managed by UMC shows the chances of suspected ADRs for above mentioned medicines have already been submitted. Moreover, supporting regulations to promote and mandate clinical trials and post marketing strategies are expected to boost the growth of global market.

For instance, the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) have formulated regulatory guidelines for each phase of clinical trials. With rapid advancements in ADR database development and accurately designed information system which is further supposed to be used by research professionals for potential studies is expected to positively influence the market growth.

By geography, Asia Pacific is anticipated to growth at a highest compound annual growth rate during the forecast period. The growth of region can be credited to presence of several outsourcing organizations across the region. Consequentially, there is significant resource sharing, cost efficiency, and improved productivity which is expected to spur the demand for pharmacovigilance services in Asian countries including China, Japan, and India.

Pharmacovigilance Market Value Share Analysis, by Geography (2022)

The report titled “Pharmacovigilance Market- Global Market Share, Trends, Analysis and Forecasts, 2023-2032” offers market estimates for a period 2019 to 2032, wherein 2018 is historic period, 2020 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global Pharmacovigilance Market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.

The global Pharmacovigilance Market is segmented on the basis of type, product life cycle, service provider, process flow, therapeutic area, end-use, and geography. Based on type, the global market has been segmented into EHR Mining, Spontaneous Reporting, Cohort Event Monitoring, Targeted Spontaneous Reporting, and Intensified ADR Reporting. On the basis of product life cycle, the global market has been segregated into Pre-clinical, Phase I, Phase II, Phase III, and Phase IV. The service provider segment can be bifurcated into in-house and outsourcing. By process flow, the market is divided into Risk Management System, Signal Detection, and Case Data Management. Furthermore, on the basis of therapeutic area, the global market is segmented into Respiratory Systems, Oncology, Cardiology, Neurology, and Others. By, end-use, the global pharmacovigilance market can be segmented into Medical Device Manufacturers, Biotechnology Companies, Pharmaceuticals, and Others. Based on geography, the global Pharmacovigilance Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

North America is sub-segmented into the United States, Canada and Rest of North America. Europe is sub-segmented into Germany, United Kingdom, Belgium, Spain, and Rest of Europe. Asia Pacific is sub-segmented into China, Japan, India, Australia, and Rest of Asia Pacific. Middle East & Africa is sub-segmented into Saudi Arabia, the UAE, and Rest of Middle East & Africa. South America is sub-segmented into Brazil and Rest of South America.

The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment and would identify the segment of the company focusing on Pharmacovigilance. Further, market share of prominent companies in the global Pharmacovigilance Market would also be estimated.

The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, swot analysis, and research and development focus of all the Pharmacovigilance device companies. The global Pharmacovigilance Market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the Pharmacovigilance business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global Pharmacovigilance Market.

Some of the prominent player involved in global Pharmacovigilance Market include Accenture, ArisGlobal, BioClinica Inc., Capgemini, Cognizant, FMD K&L, IBM Corporation, ICON plc., IQVIA, ITClinical, Laboratory Corporation of America Holdings, Linical Accelovance, PAREXEL International Corporation, TAKE Solutions Ltd., United BioSource Corporation, and Wipro Ltd.

Segmentation:

By Type:

EHR Mining
Spontaneous Reporting
Cohort Event Monitoring
Targeted Spontaneous Reporting
Intensified ADR Reporting

By Product Life Cycle:

Pre-clinical
Phase I
Phase II
Phase III
Phase IV

By Service Provider:

Outsourcing
In-House

By Process Flow:

Risk Management System
Signal Detection
Case Data Management

By Therapeutic Area:

Respiratory Systems
Oncology
Cardiology
Neurology
Others

By End-Use:

Medical Device Manufacturers
Biotechnology Companies
Pharmaceuticals
Others

By Geography

North America
- United States
- Canada
- Rest of North America
Europe
- Germany
- United Kingdom
- Belgium
- Spain
- Rest of Europe
Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Rest of Middle East & Africa
South America
- Brazil
- Rest of South America

Table Of Content

Introduction
- Research Objectives
- Report Assumptions
- Research Methodology
- Abbreviations
Preface
- Market Definition
- Report Scope and Market Segmentation
- Research Highlights
Market Synopsis: Global Pharmacovigilance Market
Global Pharmacovigilance Market Qualitative Analysis
- Trends
  - Market trends
  - Technology Trends
- PESTEL Analysis (For 3 prominent countries)
- Market Influencers
  - Driving Forces
  - Hindering Forces
  - Opportunities
- COVID-19 impact
Global Pharmacovigilance Market Analysis and Forecast, by Type
- Overview and definitions
- Key segment analysis
- Global Pharmacovigilance Market Estimates (US$ Mn), by Type, 2019 – 2032
  - EHR Mining
  - Spontaneous Reporting
  - Cohort Event Monitoring
  - Targeted Spontaneous Reporting
  - Intensified ADR Reporting

Global Pharmacovigilance Market Analysis and Forecast, by Clinical Trial Phase
- Overview and definitions
- Key segment analysis
- Global Pharmacovigilance Market Estimates (US$ Mn), by Clinical Trial Phase, 2019 – 2032
  - Pre-clinical
  - Phase I
  - Phase II
  - Phase III
  - Phase IV

Global Pharmacovigilance Market Analysis and Forecast, by Service Provider
- Overview and definitions
- Key segment analysis
- Global Pharmacovigilance Market Estimates (US$ Mn), by Service Provider, 2019 – 2032
  - Outsourcing
  - In-House

Global Pharmacovigilance Market Analysis and Forecast, by Process Flow
- Overview and definitions
- Key segment analysis
- Global Pharmacovigilance Market Estimates (US$ Mn), by Process Flow, 2019 – 2032
  - Risk Management System
  - Signal Detection
  - Case Data Management

Global Pharmacovigilance Market Analysis and Forecast, by End Use
- Overview and definitions
- Key segment analysis
- Global Pharmacovigilance Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Medical Device Manufacturers
  - Hospitals
  - Pharmaceutical companies
  - Others

Global Pharmacovigilance Market Analysis and Forecast, by Region
- Overview and definitions
- Key segment analysis
- Global Pharmacovigilance Market Estimates (US$ Mn), by Region, 2019 – 2032
  - North America
  - Europe
  - Asia Pacific
  - Middle East & Africa
  - South America

North America Pharmacovigilance Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- North America Pharmacovigilance Market Estimates (US$ Mn), by Type, 2019 – 2032
  - EHR Mining
  - Spontaneous Reporting
  - Cohort Event Monitoring
  - Targeted Spontaneous Reporting
  - Intensified ADR Reporting
- North America Pharmacovigilance Market Estimates (US$ Mn), by Clinical Trial Phase, 2019 – 2032
  - Pre-clinical
  - Phase I
  - Phase II
  - Phase III
  - Phase IV
- North America Pharmacovigilance Market Estimates (US$ Mn), by Service Provider, 2019 – 2032
  - Outsourcing
  - In-House
- North America Pharmacovigilance Market Estimates (US$ Mn), by Process Flow, 2019 – 2032
  - Risk Management System
  - Signal Detection
  - Case Data Management
- North America Pharmacovigilance Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Medical Device Manufacturers
  - Hospitals
  - Pharmaceutical companies
  - Others
- North America Pharmacovigilance Market Estimates (US$ Mn), Country, 2019 – 2032
  - United States
  - Canada
  - Rest of North America

Europe Pharmacovigilance Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Europe Pharmacovigilance Market Estimates (US$ Mn), by Type, 2019 – 2032
  - EHR Mining
  - Spontaneous Reporting
  - Cohort Event Monitoring
  - Targeted Spontaneous Reporting
  - Intensified ADR Reporting
- Europe Pharmacovigilance Market Estimates (US$ Mn), by Clinical Trial Phase, 2019 – 2032
  - Pre-clinical
  - Phase I
  - Phase II
  - Phase III
  - Phase IV
- Europe Pharmacovigilance Market Estimates (US$ Mn), by Service Provider, 2019 – 2032
  - Outsourcing
  - In-House
- Europe Pharmacovigilance Market Estimates (US$ Mn), by Process Flow, 2019 – 2032
  - Risk Management System
  - Signal Detection
  - Case Data Management
- Europe Pharmacovigilance Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Medical Device Manufacturers
  - Hospitals
  - Pharmaceutical companies
  - Others
- Europe Pharmacovigilance Market Estimates (US$ Mn), Country, 2019 – 2032
  - Germany
  - United Kingdom
  - Italy
  - France
  - Spain
  - Rest of Europe

Asia Pacific Pharmacovigilance Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Asia Pacific Pharmacovigilance Market Estimates (US$ Mn), by Type, 2019 – 2032
  - EHR Mining
  - Spontaneous Reporting
  - Cohort Event Monitoring
  - Targeted Spontaneous Reporting
  - Intensified ADR Reporting
- Asia Pacific Pharmacovigilance Market Estimates (US$ Mn), by Clinical Trial Phase, 2019 – 2032
  - Pre-clinical
  - Phase I
  - Phase II
  - Phase III
  - Phase IV
- Asia Pacific Pharmacovigilance Market Estimates (US$ Mn), by Service Provider, 2019 – 2032
  - Outsourcing
  - In-House
- Asia Pacific Pharmacovigilance Market Estimates (US$ Mn), by Process Flow, 2019 – 2032
  - Risk Management System
  - Signal Detection
  - Case Data Management
- Asia Pacific Pharmacovigilance Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Medical Device Manufacturers
  - Hospitals
  - Pharmaceutical companies
  - Others
- Asia Pacific Pharmacovigilance Market Estimates (US$ Mn), Country, 2019 – 2032
  - Japan
  - India
  - China
  - South Korea
  - Australia
  - Rest of Asia Pacific

Middle East & Africa Pharmacovigilance Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Middle East & Africa Pharmacovigilance Market Estimates (US$ Mn), by Type, 2019 – 2032
  - EHR Mining
  - Spontaneous Reporting
  - Cohort Event Monitoring
  - Targeted Spontaneous Reporting
  - Intensified ADR Reporting
- Middle East & Africa Pharmacovigilance Market Estimates (US$ Mn), by Clinical Trial Phase, 2019 – 2032
  - Pre-clinical
  - Phase I
  - Phase II
  - Phase III
  - Phase IV
- Middle East & Africa Pharmacovigilance Market Estimates (US$ Mn), by Service Provider, 2019 – 2032
  - Outsourcing
  - In-House
- Middle East & Africa Pharmacovigilance Market Estimates (US$ Mn), by Process Flow, 2019 – 2032
  - Risk Management System
  - Signal Detection
  - Case Data Management
- Middle East & Africa Pharmacovigilance Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Medical Device Manufacturers
  - Hospitals
  - Pharmaceutical companies
  - Others
- Middle East & Africa Pharmacovigilance Market Estimates (US$ Mn), Country, 2019 – 2032
  - Saudi Arabia
  - UAE
  - South Africa
  - Rest of Middle East

South America Pharmacovigilance Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- South America Pharmacovigilance Market Estimates (US$ Mn), by Type, 2019 – 2032
  - EHR Mining
  - Spontaneous Reporting
  - Cohort Event Monitoring
  - Targeted Spontaneous Reporting
  - Intensified ADR Reporting
- South America Pharmacovigilance Market Estimates (US$ Mn), by Clinical Trial Phase, 2019 – 2032
  - Pre-clinical
  - Phase I
  - Phase II
  - Phase III
  - Phase IV
- South America Pharmacovigilance Market Estimates (US$ Mn), by Service Provider, 2019 – 2032
  - Outsourcing
  - In-House
- South America Pharmacovigilance Market Estimates (US$ Mn), by Process Flow, 2019 – 2032
  - Risk Management System
  - Signal Detection
  - Case Data Management
- South America Pharmacovigilance Market Estimates (US$ Mn), by End Use, 2019 – 2032
  - Medical Device Manufacturers
  - Hospitals
  - Pharmaceutical companies
  - Others
- South America Pharmacovigilance Market Estimates (US$ Mn), Country, 2019 – 2032
  - Brazil
  - Rest of South America

Competition Analysis – Pharmacovigilance Market
- Market Composition
- Market Share Analysis (%), by Supplier (2021)
- Company Profiles
  - Accenture
    - Business overview
    - Geographic presence
    - Product portfolio
    - Financial facts
    - Relevant news and strategic view
  - Bristol-Myers Squibb
  - Clinquest Group B.V.
  - Cognizant Technology Solutions
  - BioClinica Inc.
  - Hoffmann-La Roche Ltd.
  - iMEDGlobal,
  - Labcorp Drug Development
  - Linical Americas
  - Novartis AG
  - PAREXEL International Corporation
  - Pfizer Inc.
  - Pharmaceutical Product Development LLC. (PPD)
  - Changsha Weightke Data Technology Co., Ltd.
  - Quintiles Transnational Holdings Inc.
  - Sanofi SA
  - Boehringer Ingelheim International GmbH
  - Wipro Ltd.

Conclusion & Recommendations

Request Sample

Request for Customization

Call with the Author

Frequently asked questions about this report

What segments are covered in the pharmacovigilance market report?

The global Pharmacovigilance market segmented on the basis of type, product life cycle, service provider, process flow, therapeutic area, end-use, and geography.

what are the prominent pharmacovigilance market players across the globe?

Major players operating in the global Pharmacovigilance market include Accenture, ArisGlobal, BioClinica Inc., Capgemini, Cognizant, FMD K&L, IBM Corporation, ICON plc., IQVIA, ITClinical, Laboratory Corporation of America Holdings, Linical Accelovance, PAREXEL International Corporation, TAKE Solutions Ltd., United BioSource Corporation, and Wipro Ltd..

What is the estimated growth rate of the global pharmacovigilance market?

The pharmacovigilance market is geared to grow at a CAGR of 14.5% by 2032.

What is the time duration considered while assessing the market?

The pharmacovigilance analysis market has been assessed for the years 2023 to 2032.

What was the market for pharmacovigilance valued at in 2021?

The pharmacovigilance market was valued at US$ 4.9 billion in 2021.

What are the major driving factors and opportunities in the pharmacovigilance market?

Growing instances of adverse drug responses, rising drug consumption, expanding drug discovery rates, rising toxic side effects, and a growing tendency of outsourcing pharmacovigilance activities are some of the main drivers propelling the market’s expansion.